TWiV 895: COVID-19 clinical update #112 with Dr. Daniel Griffin

This Week in Virology

Vincent Racaniello

Vincent, Microbe, Medicine, Microbiology, Racaniello, Infection, Virus, Virology, Pathogen, Infectious, Twiv, Science & Medicine

4.8 • 2.2K Ratings

🗓️ 30 April 2022

⏱️ 36 minutes

🔗️ Recording | iTunes | RSS

🧾️ Download transcript

Summary

In COVID-19 clinical update #112, Dr. Griffin reviews seroprevalence of infection-induced antibodies, Moderna filing for vaccine authorization in young children, public health impact of vaccines in US, FDA approval of first treatment for young children, phase 2 data for Sabizabulin, and post infection inflammation. Subscribe (free): Apple Podcasts, Google Podcasts, RSS, email Become a patron of TWiV! Links for this episode Seroprevalence of Infection-Induced Antibodies (CDC) Authorization for Vaccine in Young Children Filed (Moderna) Public Health Impact of Vaccines in US (BMJ) FDA authorizes first approved treatment for children (FDA) Phase 2 Data for Sabizabulin (Veru Pharma) Clinical Characteristics of Post Infection Inflammation (The Lancet) Fact Sheet for Providers on Evusheld (FDA) Fact Sheet for Providers on Paxlovid (FDA) Provider Referral for EvuSheld (Northwell Health) Contribute to ASTMH fundraiser at PWB Dr. Griffin’s treatment guide (pdf) Letters read on TWiV 895 Timestamps by Jolene. Thanks! Intro music is by Ronald Jenkees Send your questions for Dr. Griffin to [email protected]

Transcript

Click on a timestamp to play from that location

0:00.0	This week in virology, the podcast about viruses, the kind that make you sick.
0:10.4	From micro TV, this is Twiv this week in virology, episode 895 recorded on April 28th, 2022.
0:21.6	I'm Vincent Racken Yellow and you're listening to the podcast all about viruses.
0:25.9	Joining me today from New York, Daniel Griffin.
0:29.6	Hello, everyone.
0:30.8	It's update number 112.
0:33.6	Can't wait to hear the hot off the presses, Daniel.
0:36.7	Okay.
0:37.3	Yeah, as you're referring to Vincent, I sent you my update about an hour ago and then I had to update it again.
0:44.5	So this just, yeah, stuff keeps happening.
0:46.5	But let's get right into a bit of a lot to cover today.
0:49.3	Yesterday is not hours to recover, but tomorrow is hours to win or to lose.
0:56.3	And that's by President Lyndon B. Johnson, you know, spending last weekend down in DC,
1:02.2	had me thinking about presidents and that directed me this way.
1:06.6	But also thinking about hopefully we still have a bit ahead of us here and we can learn from
1:13.7	what we've done in the past and we can see some success going forward.
1:17.2	So first part of our update is expanded access and education for COVID therapeutics.
1:23.5	I love the fact that they're actually throwing education in there.
1:26.8	People want to know, they want to be educated about their choices and options.
1:31.9	So the US government has a plan aimed at getting the pill.
1:35.2	Actually, it's very tax-loved focused.
1:38.0	The pill called tax-loved to additional people who otherwise could face a more serious COVID illness.
	...

Please login to see the full transcript.

Previous episode | Next episode

Disclaimer: The podcast and artwork embedded on this page are from Vincent Racaniello, and are the property of its owner and not affiliated with or endorsed by Tapesearch.

Generated transcripts are the property of Vincent Racaniello and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.